Technion City, Haifa, Israel · Health Care · Form D filed Aug 21, 2026
NurExone Biologic Inc. raised $450K
NurExone Biologic Inc. is a biotechnology company based in Technion City, Haifa, Israel. In a Form D filed with the SEC on August 21, 2026, it reported raising $450,456 from 2 investors as part of an offering of up to $450,456. The first sale in the offering took place on August 20, 2026.
- 11th Form D since 2023. Earlier new notices: Jul 2, 2026 · Mar 18, 2026 · Aug 27, 2025 · Apr 22, 2025 · Jan 22, 2025 · Mar 25, 2024 and more. All filings on EDGAR
$6.7M raised since 2020
11 Form D offerings, as reported to the SEC, the first in Oct 2, 2023. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 21, 2026 | $450K | $450K | 2 |
| Jul 2, 2026 | $442K | $442K | 2 |
| Mar 18, 2026 | $280K | $280K | 4 |
| Aug 27, 2025 | $148K | $243K | 1 |
| Apr 22, 2025 | $1.6M | $3.8M | 1 |
| Jan 22, 2025 | $435K | $435K | 6 |
| Mar 25, 2024 | $43K | $43K | 1 |
| Mar 25, 2024 | $1M | $1M | 4 |
and 3 earlier.
Lead score
6 out of 100
young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $450,456
- Offering size
- $450,456
- Investors so far
- 2
- First sale
- August 20, 2026
- Securities offered
- Equity, Options or warrants, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Technion City, Haifa, Israel
- Incorporated
- Ontario, Canada, 2025
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $450,456 | $450,456 | 2 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 17, 2026 · August 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Immuno Cancer Biotherapeutics, Inc.
Canton, SD · filed Oct 15First Form D